绿新生物科技(01084)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01084 绿新生物科技

未开盘 09-14 15:43:44

0.660

-0.010

-1.49%

最高0.665	最低0.655	成交量1.40万
今开0.660	昨收0.670	日振幅1.49%
总市值5.77亿	流通市值5.77亿	总股本8.74亿
成交额9,280	换手率0.00%	流通股本8.74亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01084","market":"HK","secType":"STK","nameCN":"绿新生物科技","latestPrice":0.66,"timestamp":1789371824490,"preClose":0.67,"halted":0,"volume":14000,"delay":0,"changeRate":-0.01492537313432837,"floatShares":874000000,"shares":874000000,"eps":0.008920268637985803,"marketStatus":"未开盘","change":-0.01,"latestTime":"09-14 15:43:44","open":0.66,"high":0.665,"low":0.655,"amount":9280,"amplitude":0.014925,"askPrice":0.66,"askSize":90000,"bidPrice":0.655,"bidSize":4000,"shortable":0,"etf":0,"ttmEps":0.02336689505470803,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789435800000},"marketStatusCode":0,"adr":0,"listingDate":1571241600000,"exchange":"SEHK","adjPreClose":0.67,"dividendRate":0.018182,"openAndCloseTimeList":[[1789349400000,1789358400000],[1789362000000,1789372800000]],"volumeRatio":1.0000000100000002,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01084","defaultTab":"news","newsList":[{"id":"1123920168","title":"绿新生物科技2026年中期业绩：股份奖励计划可授予数量修订","url":"https://stock-news.laohu8.com/highlight/detail?id=1123920168","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1123920168?lang=zh_cn&edition=full","pubTime":"2026-09-04 18:46","pubTimestamp":1788518813,"startTime":"0","endTime":"0","summary":"本季度信息\n绿新生物科技于2026年8月31日发布的截至2026年6月30日止六个月中期业绩公告中，提及了关于股份奖励计划的相关信息。根据补充公告，董事会澄清并修订了中期业绩公告中所披露的股份奖励计划项下可供授予的受托人持有的股份数目：截至2026年1月1日为6,530,000股，截至2026年6月30日为7,010,000股。上述修订不会影响原公告中披露的其他资料，公告内容除上述更正外保持不变。\n","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"绿新生物科技2026年中期业绩：股份奖励计划可授予数量修订","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01084"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137549693","title":"绿新生物科技更新2026年8月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1137549693","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1137549693?lang=zh_cn&edition=full","pubTime":"2026-09-02 10:06","pubTimestamp":1788314801,"startTime":"0","endTime":"0","summary":"绿新生物科技有限公司于2026年9月2日发布2026年8月股份变动月报表，报告期为2026年8月。公告显示，截至2026年8月31日，公司在本月内未发生新增发行、购回、注销或库藏股等事项，股本结构稳定。已发行股份总数与上月末保持一致，为874,120,000股，其中库藏股份数量为0股，亦未出现变动。报告期内，公司未发生股份期权、权证或可换股票据的授予、行使或失效记录。公司声明，已遵守香港联合交易所有限公司的上市规则以及其他适用的法律法规。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01084"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165306104","title":"绿新生物科技宣布不派发中期股息","url":"https://stock-news.laohu8.com/highlight/detail?id=1165306104","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165306104?lang=zh_cn&edition=full","pubTime":"2026-09-01 00:37","pubTimestamp":1788194221,"startTime":"0","endTime":"0","summary":"8月31日，路透消息——绿新生物科技有限公司（股票代码：1084.HK）披露2026年上半年度财务报告。\n数据显示，该公司上半年净亏损达300万元人民币。与此同时，公司明确表示，不建议派发2026年中期股息。\n值得注意的是，尽管处于亏损状态，公司营收表现却颇为亮眼。上半年收入同比增长30.4%，达到了5.348亿元人民币的规模。\n关于该公司的更多详细报道，可继续关注1084.HK的相关资讯更新。\n（本文基于Reuters Briefs信息源整理）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01084","BK1129"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663016370","title":"绿新生物科技(01084)发布中期业绩 股东应占亏损139.2万元 同比减少88.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663016370","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663016370?lang=zh_cn&edition=full","pubTime":"2026-08-31 22:34","pubTimestamp":1788186896,"startTime":"0","endTime":"0","summary":"智通财经APP讯，绿新生物科技(01084)发布截至2026年6月30日止六个月业绩，该集团期内收益为5.35亿元，同比增长30.45%。公司拥有人应占亏损139.2万元，同比减少88.47%;每股亏损0.002元。于2026年上半年，收益增加主要归因于所有主要类型亲水胶体产品的收益增加，主要由于就精制卡拉胶的销售实施价格主导的销售策略;及期内市场动态及集团其他亲水胶体产品的成本效益所带动的需求增长，使销量增加。卡拉胶及琼脂产品的总收益占集团总收益的 76.1%，较2025年上半年轻微增加0.3%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489956.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1129","01084"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126557651","title":"绿新生物科技2026年中期营收5.35亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1126557651","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1126557651?lang=zh_cn&edition=full","pubTime":"2026-08-31 22:28","pubTimestamp":1788186483,"startTime":"0","endTime":"0","summary":"绿新生物科技公布的公告数据显示，2026年上半年实现营收5.35亿元，同比增长30.4%。主要受精制卡拉胶、琼脂、魔芋及复配等亲水胶体产品销售量提升带动，其中精制卡拉胶因实施价格主导的销售策略同比增长49.4%，琼脂产品收入增长3.5%，魔芋产品收入增长47.6%，复配产品收入则上升24.2%。本期经营活动现金流净额为1.23亿元，较上年同期的0.15亿元大幅提升约7.4倍。精制卡拉胶于2026年上半年收入2.78亿元，受市场供需变化及公司价格策略影响，增幅显著。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"绿新生物科技2026年中期营收5.35亿元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01084"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124661890","title":"绿新生物科技（01084）拟于8月31日召开董事会审议中期业绩及中期股息","url":"https://stock-news.laohu8.com/highlight/detail?id=1124661890","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124661890?lang=zh_cn&edition=full","pubTime":"2026-08-19 18:06","pubTimestamp":1787133996,"startTime":"0","endTime":"0","summary":"绿新生物科技（01084）公告称，公司董事会已安排于2026年8月31日（星期一）召开会议，主要议程包括：一、审核及批准公司及其附属公司截至2026年6月30日止六个月的未经过审计的中期业绩；二、考虑宣派中期股息（如有）。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01084"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658972378","title":"绿新生物科技中期预亏收窄 卡拉胶销量提升带动经营现金流入增超7倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2658972378","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658972378?lang=zh_cn&edition=full","pubTime":"2026-08-12 19:53","pubTimestamp":1786535580,"startTime":"0","endTime":"0","summary":"8月12日，绿新生物科技（01084）发布公告，预计截至2026年6月30日的六个月内，公司预计录得本公司拥有人的应占亏损净额介乎约100万元至400万元，而2025年同期，本公司拥有人的应占亏损净额为1207万元。这表明公司的表现有所改善，主要是由于卡拉胶产品销量因公司具竞争优势的定价策略而增加，推动了报告期间的收益及毛利增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608123839353164.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608123839353164.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["SPHQ","BK1129","BK4585","01084","159399","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658797659","title":"绿新生物科技(01084)发盈警 预期中期股东应占亏损净额同比收窄至约100万元至400万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2658797659","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658797659?lang=zh_cn&edition=full","pubTime":"2026-08-12 18:52","pubTimestamp":1786531966,"startTime":"0","endTime":"0","summary":"智通财经APP讯，绿新生物科技(01084)发布公告，经初步审阅现有可得资料(包括但不限于本集团截至2026年6月30日止6个月(报告期间)的未经审核综合管理账目)后，董事会谨此通知本公司股东(股东)及有意投资者，于报告期间，本公司预期取得本公司拥有人应占亏损净额介乎约人民币100万元至人民币400万元，而截至2025年6月30日止6个月的本公司拥有人应占亏损净额为人民币1207万元。本集团的表现有所改善，主要是由于卡拉胶产品销量因本集团具竞争优势的定价策略而增加，推动报告期间的收益及毛利增长。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1479075.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01084","BK1129"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126444103","title":"绿新生物科技：卡拉胶产品销量攀升，中期业绩预期向好","url":"https://stock-news.laohu8.com/highlight/detail?id=1126444103","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1126444103?lang=zh_cn&edition=full","pubTime":"2026-08-12 18:51","pubTimestamp":1786531895,"startTime":"0","endTime":"0","summary":"绿新生物科技的业绩正迎来强劲推动力——主要源于其卡拉胶产品销量的显著增长，预期中期业绩将因此录得亮眼表现。随着市场对卡拉胶需求的持续升温，该公司核心产品的销售规模不断扩大。从业务结构来看，卡拉胶作为绿新生物科技的关键产品线，其市场表现往往能左右公司整体业绩走势。观察人士认为，若销量增长势头得以延续，绿新生物科技的中期业绩不仅将超出市场预期，更可能为后续的年度盈利奠定坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1129","01084"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114128735","title":"绿新生物科技(01084)预计2026上半年亏损收窄至1至4百万元 经营现金流入同比增逾7倍","url":"https://stock-news.laohu8.com/highlight/detail?id=1114128735","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114128735?lang=zh_cn&edition=full","pubTime":"2026-08-12 18:51","pubTimestamp":1786531890,"startTime":"0","endTime":"0","summary":"绿新生物科技有限公司8月12日公告，根据对现有资料的初步审阅，公司预计截至2026年6月30日止六个月归属公司拥有人应占亏损净额介乎人民币1百万元至人民币4百万元，较2025年同期的亏损人民币12.07百万元大幅收窄。受益于具有竞争力的定价策略，报告期间销售收入及毛利均实现增长。报告期内，集团经营现金流入净额较2025年同期增长逾7倍。公司计划于2026年8月底之前发布完整的中期业绩公告。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01084"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167617759","title":"绿新生物科技预期2026年上半年净亏损100万至400万元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=1167617759","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1167617759?lang=zh_cn&edition=full","pubTime":"2026-08-12 18:51","pubTimestamp":1786531870,"startTime":"0","endTime":"0","summary":"绿新生物科技（GREEN FRESH BIO）发布业绩预告，预计截至2026年6月30日的六个月期间，将录得归属于公司股东的净亏损。这一数字大致锁定在100万元人民币至400万元人民币的区间之内。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01084","BK1129"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119189414","title":"绿新生物科技更新2026年7月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1119189414","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1119189414?lang=zh_cn&edition=full","pubTime":"2026-08-03 12:02","pubTimestamp":1785729738,"startTime":"0","endTime":"0","summary":"绿新生物科技有限公司于2026年8月3日发布截至2026年7月31日的证券变动月报表。公告显示，公司报告期内已发行股本及库藏股数量保持不变，股本结构维持稳定。报告期内，绿新生物科技普通股注册股本总额为50,000,000,000股，面值为每股港币0.01元，注册股本合计仍为港币500,000,000元，与上月保持一致。公告显示，绿新生物科技在2026年7月期间没有新增发行、购回、注销或库藏股变动。公司在公告中确认，目前已符合香港联交所关于公众持股量的相关规定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01084"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100738946","title":"绿新生物科技（01084）旗下环保三文治盒获香港环保署列入“绿色餐具平台”","url":"https://stock-news.laohu8.com/highlight/detail?id=1100738946","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100738946?lang=zh_cn&edition=full","pubTime":"2026-07-08 20:15","pubTimestamp":1783512941,"startTime":"0","endTime":"0","summary":"2026年7月8日，绿新生物科技有限公司公布，其全资附属公司格林（中国）科技发展有限公司代理的BOTEC品牌环保透明窗口三文治盒已获香港环境保护署批准，列入“绿色餐具平台”。董事会表示，产品成功进入“绿色餐具平台”将有助于提升集团品牌在香港及国际市场的知名度与竞争力，并对业务发展产生积极影响。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01084"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649955059","title":"绿新生物科技(01084)：旗下BOTEC品牌环保透明窗口三文治盒通过审批成为香港环保署绿色餐具平台列表产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2649955059","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649955059?lang=zh_cn&edition=full","pubTime":"2026-07-08 20:14","pubTimestamp":1783512850,"startTime":"0","endTime":"0","summary":"董事会认为，是次获纳入绿色餐具平台，不仅代表集团的BOTEC品牌环保三文治盒在环保标准上获得充分的认可，更是集团在推动可持续发展及绿色科技产品发展上的一个重要里程碑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1464902.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01084","BK1129"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162936371","title":"绿新生物科技6月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1162936371","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1162936371?lang=zh_cn&edition=full","pubTime":"2026-07-02 16:30","pubTimestamp":1782981056,"startTime":"0","endTime":"0","summary":"绿新生物科技有限公司于2026年7月2日发布截至2026年6月30日的证券变动月报表。公告显示，公司本月内并无新增发行、购回或注销股份活动，整体股本结构保持稳定。已发行股份数目截至6月底仍为874,120,000股，库藏股数目为0，已发行股份总数与上月底一致。公司确认已满足香港联交所相关的公众持股量要求。据公告，6月份并无股份期权、权证、可换股票据及其他协议或安排导致的股份变动，亦未发生任何股份购回或注销。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01084"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186061522","title":"绿新生物科技2026年5月股份变动月报表：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1186061522","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1186061522?lang=zh_cn&edition=full","pubTime":"2026-06-02 15:36","pubTimestamp":1780385779,"startTime":"0","endTime":"0","summary":"绿新生物科技有限公司（股票代码：01084）于2026年6月2日发布截至2026年5月31日的股份变动月报表，报告期内公司注册股本维持在500,000,000港元，总面值为每股0.01港元，相当于50,000,000,000股注册股份数量。\n公司已发行普通股数量在5月末为874,120,000股，与上月底持平，期内无新增发行、购回、注销或库藏股活动。公司确认已满足香港联合交易所有限公司相关上市规则要求，并将继续遵循适用法律法规开展业务。\n上述公告由公司秘书苏智文签署并对外公布。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01084"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138454302","title":"绿新生物科技2026年4月股份变动月报：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1138454302","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1138454302?lang=zh_cn&edition=full","pubTime":"2026-05-04 11:52","pubTimestamp":1777866726,"startTime":"0","endTime":"0","summary":"2026年5月4日，绿新生物科技（股票代码：01084）发布2026年4月股份变动月报。公告显示，截至2026年4月30日，绿新生物科技已发行股份总数为874,120,000股，与上月保持一致，未进行任何新增发行、购回或注销活动。\n报告显示，公司普通股注册股本维持50,000,000,000股，股份面值为每股0.01港元，总注册股本折合约5.00亿港元。截至报告期末，绿新生物科技并无库存股份，已发行股份总数与此前保持不变，公司确认已符合适用的公众持股量要求。\n公告称，公司所有证券发行为董事会正式批准并遵守香港联交所《上市规则》及其他适用法律法规。公告由公司秘书苏智文签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01084"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106679232","title":"绿新生物科技授予董事股份购回授权，规模达已发行股本一成","url":"https://stock-news.laohu8.com/highlight/detail?id=1106679232","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1106679232?lang=zh_cn&edition=full","pubTime":"2026-04-24 21:26","pubTimestamp":1777037175,"startTime":"0","endTime":"0","summary":"绿新生物科技于最新公告中披露，董事会拟在公司股东年度大会上寻求授权，回购最多相当于已发行股本10%的股份。董事会认为，适度回购可增强每股资产净值及每股盈利水平，符合公司及股东的整体利益。该公司强调，若获授回购授权，董事会将根据市况及财务状况酌情决定回购时机与价格。董事会表示，此次措施旨在强化公司资本结构，以实现长期价值提升与股东利益保护。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"绿新生物科技授予董事股份购回授权，规模达已发行股本一成","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01084"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160850559","title":"绿新生物科技2025年营收下滑聚焦海藻与生物降解多元化布局","url":"https://stock-news.laohu8.com/highlight/detail?id=1160850559","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1160850559?lang=zh_cn&edition=full","pubTime":"2026-04-24 21:24","pubTimestamp":1777037075,"startTime":"0","endTime":"0","summary":"绿新生物科技于2025财年录得收益人民币904.7百万元，同比下降8.6%；毛利为人民币167.2百万元，毛利率降至18.5%。年内溢利人民币5.4百万元，较上一财年的人民币60.9百万元大幅减少，反映宏观经济和海外市场需求放缓对整体业绩造成压力。截至2025年12月31日，集团总资产达人民币1,632.3百万元，负债总额为人民币785.2百万元，净资产约人民币847.1百万元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"绿新生物科技2025年营收下滑聚焦海藻与生物降解多元化布局","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01084"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110572544","title":"绿新生物科技3月股份变动月报，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1110572544","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1110572544?lang=zh_cn&edition=full","pubTime":"2026-04-02 12:42","pubTimestamp":1775104924,"startTime":"0","endTime":"0","summary":"绿新生物科技有限公司（股票代码：01084）于2026年4月2日发布了截至2026年3月31日的股份变动月报。报告显示，公司于本月未进行新增发行或购回注销，股本结构保持不变。\n公司法定注册股本为50,000,000,000股，面值每股0.01港元，法定注册股本总额为500,000,000港元。报告期内，上月底及本月底的已发行股份数均为874,120,000股，无库藏股，未发生任何股份变动。\n公司声明已遵守香港联交所《上市规则》及相关法律法规，所有披露信息均经董事会正式授权批准。本次公告由公司秘书苏智文签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01084"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.greenfreshfood.com","stockEarnings":[{"period":"1week","weight":-0.0222},{"period":"1month","weight":-0.0571},{"period":"3month","weight":-0.0294},{"period":"6month","weight":-0.012},{"period":"1year","weight":-0.012},{"period":"ytd","weight":0.0185}],"compareEarnings":[{"period":"1week","weight":-0.0195},{"period":"1month","weight":-0.0079},{"period":"3month","weight":0.0173},{"period":"6month","weight":-0.0426},{"period":"1year","weight":-0.0557},{"period":"ytd","weight":-0.0278}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"绿新生物科技有限公司是一家主要从事生产海藻及植物性亲水胶体产品的投资控股公司。该公司主要通过五大分部运营业务。琼脂销售分部主要从事应用于果冻等琼脂产品的制造及销售。卡拉胶制造及销售分部主要从事应用于糖果零食类卡拉胶产品的制造及销售。魔芋产品制造及销售分部主要从事应用于魔芋产品的制造及销售。复配产品制造及销售分部主要从事应用于肉制品等复配产品的制造及销售。其他分部主要从事奶粉销售等。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.008702},{"month":2,"riseRate":0.571429,"avgChangeRate":-0.066063},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.011272},{"month":4,"riseRate":0.714286,"avgChangeRate":0.096795},{"month":5,"riseRate":0.571429,"avgChangeRate":0.104435},{"month":6,"riseRate":0.571429,"avgChangeRate":0.009845},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.041188},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.009989},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.046387},{"month":10,"riseRate":0.333333,"avgChangeRate":0.040353},{"month":11,"riseRate":0.142857,"avgChangeRate":-0.044514},{"month":12,"riseRate":0.714286,"avgChangeRate":0.033133}],"exchange":"SEHK","name":"绿新生物科技","nameEN":"GREEN FRESH BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"绿新生物科技(01084)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供绿新生物科技(01084)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"绿新生物科技,01084,绿新生物科技股票,绿新生物科技股票老虎,绿新生物科技股票老虎国际,绿新生物科技行情,绿新生物科技股票行情,绿新生物科技股价,绿新生物科技股市,绿新生物科技股票价格,绿新生物科技股票交易,绿新生物科技股票购买,绿新生物科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"绿新生物科技(01084)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供绿新生物科技(01084)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}